DUBLIN, Ireland--(BUSINESS WIRE)--ICON (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced financial guidance for 2008. 2008 net revenue is expected to be in the range of $750 - $770 million, compared to a range of $615 - $625 million which has already been guided for 2007. 2008 net income per diluted share is forecast to be in the range of $2.27 - $2.36 compared to $1.82 - $1.85 guided for 2007.
